Actively Recruiting
A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)
Led by Almirall, S.A. · Updated on 2025-01-29
110
Participants Needed
1
Research Sites
119 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main aim of this study is to check the safety and effectiveness of tildrakizumab regarding the alleviation of symptoms in the genital area after administration according to the summary of product characteristics (SmPC) and to access overall treatment safety and quality of life assessed on multiple scales.
CONDITIONS
Official Title
A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis of psoriasis with significant genital involvement (sPGA-G >= 3)
- Need for systemic biologic therapy according to local regulations
- Tildrakizumab must be selected as anti-IL23p19 therapy before study inclusion
- Age between 18 and 99 years
- Written informed consent according to country regulations
- Plaque psoriasis affecting at least 1% body surface area outside genital region at baseline
- Willing and able to complete study questionnaires
You will not qualify if you...
- Unwilling or unable to comply with study requirements or deemed unsuitable by investigator
- Use of any experimental treatment within 3 months prior to baseline
- Any contraindication, hypersensitivity, or intolerance to Tildrakizumab as per SmPC
- Dependence on investigator, including study site employees
- Prior treatment with Tildrakizumab
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Medizinische Universität Graz
Graz, Styria, Austria, 8020
Actively Recruiting
Research Team
S
Senior Director Regional Medical Affairs
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here